Insomnia News and Research

Latest Insomnia News and Research

FDA approves skin patch designed to treat symptoms of early Parkinson's disease

Rotigotine is a drug not previously approved in the United States. Neupro is the first transdermal patch approved for the treatment of symptoms of Parkinson's disease.

10 May 2007

New understanding of sleep

Sleep remains one of the big mysteries in biology. All animals sleep, and people who are deprived of sleep suffer physically, emotionally and intellectually. But nobody knows how sleep restores the brain.

1 May 2007

FDA approves INVEGA treatment for schizophrenia

The U.S. Food and Drug Administration (FDA) has approved INVEGA (paliperidone) Extended-Release Tablets, a new once-daily, atypical antipsychotic, for the long-term maintenance treatment of schizophrenia.

30 Apr 2007

Ranbaxy receives approval to manufacture Zolpidem tablets for insomnia

Ranbaxy Laboratories Limited (RLL), has announced that the Company has received final approval from the U.S. Food and Drug Administration to manufacture and market Zolpidem Tartrate Tablets, 5mg and 10mg.

27 Apr 2007

ADHD study to look at effects of different stimulant medications and dosages on sleep and mood

Researchers at the University of Illinois at Chicago are comparing two common stimulant drugs with a placebo to evaluate their effect on sleep and behavior in children with attention deficit hyperactivity disorder.

25 Apr 2007

FDA approves generic versions of Ambien

The U.S. Food and Drug Administration (FDA) today approved the first generic versions of Ambien (zolpidem tartrate) immediate-release tablets.

24 Apr 2007

New findings on insomnia

Those persons who are labeled a 'night owl' report more pathological symptoms related to insomnia, despite many having the opportunity to compensate for their nocturnal sleeplessness by extending their time in bed and being able to gain more total sleep time, according to a study published in the April 15th issue of the Journal of Clinical Sleep Medicine (JCSM).

16 Apr 2007

Night owls do it tougher than other insomniacs

According to a new study night owls, those who stay up late with insomnia and then sleep longer in the mornings, have more psychological symptoms than morning insomniacs and need different treatment, even though they get more sleep.

16 Apr 2007

A mild head injury can increase your chance of developing a sleep disorder

Researchers say these findings highlight the need for improved diagnosis and treatment of sleep disorders in mild traumatic brain injury patients who complain of insomnia.

4 Apr 2007

Eli Lilly acquires Hypnion

Eli Lilly and Company has announced that it has completed its acquisition of Hypnion, Inc., a privately held neuroscience drug discovery company focused on sleep disorder research.

3 Apr 2007

Fragmented sleep increases spontaneous pain in women

Sleep continuity disturbance impairs endogenous pain-inhibitory function and increases spontaneous pain in women

2 Apr 2007

Actigraphy helps assess and manage sleep disorders

Actigraphy, the use of a portable device that records movement over extended periods of time, and has been used extensively in the study of sleep and circadian rhythms, provides an acceptably accurate estimate of sleep patterns in normal, healthy adult populations and in-patients suspected of certain sleep disorders, according to practice parameters published in the April 1st issue of the journal SLEEP.

2 Apr 2007

Clinical and imaging evidence of Zolpidem effect in hypoxic encephalopathy

A new study reported that zolpidem, a drug normally used to treat insomnia, temporarily improved brain function in a patient suffering from akinetic mutism, a condition in which the person is alert but cannot speak or move.

13 Mar 2007

Prescription drug prices for U.S. residents ages 50 and older increased at about twice inflation rate

Manufacturers' prices for the 193 prescription drugs most commonly used by U.S. residents ages 50 and older increased at about twice the rate of inflation in 2006, according to an annual report released on Tuesday by AARP, Cox/Atlanta Journal-Constitution reports.

8 Mar 2007

Women in the U.S. too tired for sex

It seems American women have a problem with sleep and are not getting enough of it.

7 Mar 2007

Lilly to acquire neuroscience drug discovery co. Hypnion

Eli Lilly and Company and Hypnion, Inc. today announced that they have signed a definitive merger agreement whereby Lilly will acquire Hypnion, a privately held neuroscience drug discovery company focused on sleep disorders.

5 Mar 2007

FDA approves antidepressant Cymbalta (duloxetine HCl) for treatment of generalized anxiety disorder

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.

26 Feb 2007

Body Shop founder Roddick reveals she has Hepatitis C

Anita Roddick the founder of the Body Shop has revealed she is suffering from the disease Hepatitis C.

14 Feb 2007

Some tips for SAD sufferers

Experts say the months after Christmas when winter really sets in can be the most difficult for sufferers with Seasonal Affective Disorder (SAD).

4 Feb 2007

Snoring is not only annoying - it is bad for your health!

Snoring is a significant problem for many people, but it often goes undiagnosed or gets passed off as an irritation, with people being unaware that they are causing more damage to their health by not getting treated, especially if their snoring points to untreated Sleep Apnoea, a serious and potentially life threatening condition.

1 Feb 2007